Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 59, Issue 3, 2010, Pages 390-394

  Yamada, Shinsuke ^a   Inaba, Masaaki ^a   Okada, Shigeki ^b   Imanishi, Yasuo ^a   Mori, Katsuhito ^a   Emoto, Masanori ^a   Ishimura, Eiji ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Okada Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE METABOLISM; CALCANEUS; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BLOOD GLUCOSE; BONE AND BONES; CALCANEUS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ERYTHROPOIETIN, RECOMBINANT; GLYCOPROTEINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 76249106906     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.008     Document Type: Article

References (29)

1. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., et al. Study of osteoporotic features research group. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86 (2001) 29-31
2. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18 (2007) 427-444
3. Romero D.F., Bryer H.P., Rucinski B., et al. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif Tissue Int 56 (1995) 54-61
4. Terada M., Inaba M., Yano Y., et al. Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 22 (1998) 17-23
5. Yoshida O., Inaba M., Terada M., et al. Impaired response of human osteosarcoma (MG-63) cells to human parathyroid hormone induced by sustained exposure to high glucose. Miner Electrolyte Metab 21 (1995) 201-204
6. Inaba M., Terada M., Koyama H., et al. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res 10 (1995) 1050-1056
7. Inaba M., Nishizawa Y., Mita K., et al. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9 (1999) 525-531
8. Gopalakrishnan V., Vignesh R.C., Arunakaran J., et al. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Cell Biol 84 (2006) 93-101
9. Nagasaka S., Murakami T., Uchikawa T., et al. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr J 42 (1995) 377-383
10. Chiu Y.L., Chien K.L., Lin S.L., et al. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 109 (2008) 109-118
11. Inaba M., Okuno S., Kumeda Y., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18 (2007) 896-903
12. Kumeda Y., Inaba M., Shoji S., et al. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol 69 (2008) 556-561
13. Yamada S., Inaba M., Shidara K., et al. Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes. Life Sci 83 (2008) 516-519
14. Berger C., Langsetmo L., Joseph L., et al. Canadian Multicentre Osteoporosis Study Research Group. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 178 (2008) 1660-1668
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (2003) 5-20
16. Inaba M., Nagasue K., Okuno S., et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 39 (2002) 1261-1269
17. Kouzuma T., Uematsu Y., Usami T., et al. Study of glycated amino acid elimination for an improved enzymatic glycated albumin measurement method. Clin Chim Acta 346 (2004) 135-143
18. Tominaga M., Makino H., Yoshino G., et al. Japanese standard reference material JDS lot 2 for haemoglobin A1c. II: present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays. Ann Clin Biochem 42 (2005) 47-50
19. Hans D., Dargent-Molina P., Schott A.M., et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348 (1996) 511-514
20. Thompson P., Taylor J., Fisher A., et al. Quantitative heel ultrasound in 3180 women between 45 and 75 years of age: compliance, normal ranges and relationship to fracture history. Osteoporos Int 8 (1998) 211-214
21. Greenspan S.L., Bouxsein M.L., Melton M.E., et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res 12 (1997) 1303-1313
22. Blake G.M. Comparative performance of commercial ultrasound scanners. Proceedings of Ultrasonic Assessment of Bone III, [Stratford upon Avon, UK] (1993) 14-21
23. Hans D., Arlot M.E., Schott A.M., et al. Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass? A two-dimensional histomorphometric study. Bone 16 (1995) 295-300
24. Inaba M., Terada M., Nishizawa Y., et al. Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism 48 (1999) 904-909
25. Rishaug U., Birkeland K.I., Falch J.A., et al. Bone mass in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 55 (1995) 257-262
26. Peacock T.P., Shihabi Z.K., Bleyer A.J., et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73 (2008) 1062-1068
27. Fitzgibbons J.F., Koler R.D., and Jones R.T. Red cell age-related changes of hemoglobins A1a + b and A1c in normal and diabetic subjects. J Clin Invest 58 (1976) 820-824
28. Nakao T., Matsumoto H., Okada T., et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 38 (1998) 826-830
29. Williams M.E., Lacson Jr. E., Teng M., et al. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 70 (2006) 1503-1509